Stocks to sell

After multiple neurology experts harshly criticized Cassava Sciences’ (NASDAQ:SAVA) main thesis and the integrity of its data, I strongly recommend investors refrain from owning any shares of SAVA stock. In my many years of writing about pharmaceutical companies, I’ve never seen multiple experts criticize a drug maker so harshly. These professionals’ tremendous skepticism towards Cassava

Canopy Growth Corporation (NASDAQ:CGC) stock is losing luster on Wall Street due to its inability to deliver profits over the last two years. CGC stock momentarily zoomed on the hope of full legalization of cannabis in the U.S. However, the timing of it being completely legalized remains uncertain. CGC management has high expectations for the

Teladoc (NASDAQ:TDOC) stock slumped by more than 50% after the company’s first-quarter earnings report disappointed. TDOC reported a revenue miss of $3.28 million, caused by an abrupt drawdown in its sales cycle. It seems as though the competitive sphere is heating up in the telehealth space, causing crowdedness in the industry. Teladoc’s return on invested

Ocugen (NASDAQ:OCGN) was one of the most explosive stocks, at one point. In fact, from a December 2020 low of about 29 cents, the stock exploded to $17.65 by November 2021. All thanks to hopes for its coronavirus vaccine, Covaxin. Even Noble Financial analyst Robert LeBoyer had an outperform rating on the stock, with a

Robinhood Markets’ (HOOD) stock has collapsed, falling 74% since last autumn. The company is losing users on its trading app and racking up big losses. While Robinhood has launched several initiatives to improve its situation, HOOD stock continues to fall. Source: dennizn / Shutterstock.com Down 74% in the past six months and 88% below its

Affirm Holdings (AFRM) stock is off 70% from the end of the year, and down 48.6% from Feb. 10 when it released its December quarter results. Affirm provided an update on March 14, but essentially said operating losses would be only slightly worse at 11% to 13% of revenue. With higher interest rates from the

Snap (SNAP) earnings disappointed analysts. It now calls itself an “augmented reality company,” eschewing the social media label. Snap is husbanding cash as it waits out the social media firestorm. Investors should do the same. Source: franviser / Shutterstock.com Snap (NASDAQ:SNAP) missed earnings estimates but the stock has been surprisingly resilient. Shares went on a roller

It has been more than three weeks since the NYSE American Exchange sent Camber Energy (NYSEAMERICAN:CEI) a letter saying that it wasn’t compliant with the exchange’s continued listing standards. Fortunately for owners of CEI stock, the company was able to get an extension until May 20. While the share price took a hit after the

Snowflake (NYSE:SNOW) has many positive characteristics, including extremely rapid growth, many prominent customers, “great technology,” a CEO who has been extremely successful in the past, and a very promising initiative. Additionally, Snowflake expects its cash flow to be positive this year. However, I don’t expect SNOW stock to perform very well over the next six

Shares of Tilray (NASDAQ:TLRY) continue to slide lower and are down 70% over the last year. The company’s latest earnings showed that its share of the Canadian cannabis market is declining. A new joint venture with fellow Canadian cannabis producer Hexo Corp. (HEXO) raises more questions than it answers. Source: viewimage / Shutterstock.com Canadian cannabis

American Airlines (AAL): Credit metrics have worsened since the pandemic and the airline faces significant debt servicing costs. Renewed slowdown would imply an extended period of cash burn. United Airlines (UAL): Another airline company that has a stretched balance sheet. Focus on recovery will be on deleveraging. Equity dilution remains a possibility. Delta Air Lines

Novavax (NVAX) has dropped to a price that looks cheap if it manages to hit the low end of analyst earnings estimates. However, it’s still trading at a premium to a “worst case scenario” valuation. More disappointment could push it to lower prices. Source: pixinoo / Shutterstock.com The term “falling knife” may be cliché, yet

Salesforce (CRM) — Shares slipped below the 200-weekly moving average and have a long way to go until the next support zone. Alcoa (AA) — Has been hammered after reporting earnings numbers that failed to justify its meteoric rise. Nvidia (NVDA) — The unwind in semiconductors accelerated Thursday, causing NVDA to crack a major floor. Source:

Cable One (CABO): While a strong performer since its debut in 2015, the same can’t be said about its potential performance going forward. Carnival Corporation (CCL): Many challenges signal it’s not time to go “full steam ahead” on this cruise line operator’s shares. Caesars Entertainment (CZR): Be careful about placing a wager that it makes an

Social media company Snap (NYSE:SNAP) reported earnings Thursday afternoon. The numbers were soft across the board. The company missed earnings, missed revenues, and offered up soft guidance for next quarter as well. All in all, it was a bad report, and SNAP stock initially spiked lower on the news. Shares dropped as much as 20% in

Mullen Automotive (MULN) garnered plenty of macabre headlines for short seller’s report that took down MULN stock. In reality, even without the exposé, shares of the EV manufacturer would have likely faced serious trouble. It’s time for investors to start thinking very carefully about the electric transition. Source: Ringo Chiu / Shutterstock.com If you’re following

Mullen Automotive’s (MULN) stock continues to fall despite several recent positive announcements. The company’s share price has fallen nearly 50% in the past month. The steep and sudden selloff should be a warning sign to investors. Source: Ringo Chiu / Shutterstock Mullen Automotive (NASDAQ:MULN) is still in start-up mode and not without risk, but the electric

Home Depot (HD) — Lower spending on non-essential household items could be in the offing. In addition, the stock’s price multiples are sky high, which is a rarity for mature companies. Tesla (TSLA) — Cyclicality could catch up with Tesla. Its vehicles are “best-in-class”. However, economic throughs have previously shown to impact most discretionary companies. Visa

Rivian (RIVN) recently got another analyst to cover RIVN stock. The analyst has set a price target below its current share price. Investors might want to buy Ford (F) instead. Source: James Yarbrough / Shutterstock.com On April 11, Exane BNP Paribas initiated coverage of Rivian Automotive (NASDAQ:RIVN) with an “underperform” rating. As for RIVN stock,

New Oriental Education (EDU) stock might look like it’s taking a moonshot. However, the reality is actually bleak for the company and the stock. Investors should stay on the sidelines when it comes to New Oriental Education. Private Chinese education specialist New Oriental Education (NYSE:EDU) might have been worth investing in many years ago. However,